カテゴリー： MarketsandMarkets, 世界, 医療/バイオ

幹細胞製造の世界市場予測（～2028）：製品別、用途別、エンドユーザー別、地域別

◆英語タイトル：Stem Cell Manufacturing Market by Product (Consumables, Instruments, Stem Cell Lines), Application (Research, Clinical, Cell Tissue & Banking), End User, Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2028

MarketsandMarketsが発行した調査報告書（BT6089-23）◆商品コード：BT6089-23
◆発行会社（リサーチ会社）：MarketsandMarkets
◆発行日：2023年7月26日
◆ページ数：300
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：バイオテクノロジー
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥742,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥997,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,222,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

"幹細胞製造市場は2023年の127億米ドルから2028年には218億米ドルに達すると予測され、予測期間中の年平均成長率は11.3%" 遺伝性疾患の有病率の増加や幹細胞治療に関する規制当局の認可の増加が市場の成長を促進する主な要因として期待されています。しかし、研究や製造にかかるコストが高いため、市場の成長はある程度抑制される見込みです。幹細胞製造市場は、製品、用途、エンドユーザー、地域によって細分化されています。

"副産物、消耗品セグメントが幹細胞製造市場で最大シェア"
製品に基づき、幹細胞製造市場は消耗品、器具、幹細胞ラインに分類されます。2023年には消耗品セグメントが市場を支配しました。幹細胞を用いた研究に対する需要の高まり、政府からの資金提供やイニシアチブの増加、学術機関と製薬企業との共同研究の増加により、幹細胞製造市場における製品の成長率が高くなっています。

"用途別では、研究用途分野が幹細胞製造市場で最大のシェア"
用途別に見ると、幹細胞製造市場は研究用途、臨床用途、細胞・組織バンク用途に区分されます。2023年には、研究用途分野が幹細胞製造市場でより大きなシェアを占めました。この市場セグメントの成長は、幹細胞の細胞学的・病態生理学的研究への注目が高まっていること、研究者や医療従事者の間で幹細胞の治療効果に対する認識が高まっていること、幹細胞製品の開発・商業化を支援する官民の資金援助が拡大していること、幹細胞製品の効率的な生産スケールアップに関する技術的進歩があることなどに起因しています。

"北米：幹細胞製造市場で最大のシェア"
幹細胞製造市場で最大のシェアを占めるのは北米です。北米地域の大きなシェアは、高度なインフラ、最先端の研究機関、幹細胞研究を専門とするバイオテクノロジー企業やCROの強力なエコシステムなど、同地域で確立されたヘルスケアとバイオテクノロジー産業に起因しています。北米には、幹細胞研究に特化したプログラムや専門知識を有するトップクラスの学術機関や民間企業が存在し、幹細胞製造市場の成長に貢献しています。

"アジア太平洋：幹細胞製造市場の急成長地域"
アジア太平洋地域の幹細胞製造市場は、予測期間中に最も高いCAGRで成長すると予測されています。この背景には、個別化医療に対する需要の高まりと、幹細胞を用いた治療法の進歩があります。アジア太平洋地域の幹細胞製造市場のもう一つの主要な促進要因は、同地域の人口の多さと急速な増加です。

本レポートのために実施した一次インタビューは以下のように分類されます：
- 回答者別：供給側：63%、需要側：37%
- 役職別：Cレベル幹部-45%、ディレクターレベル-30%、その他-25%
- 国別：北米40％、欧州25％、アジア太平洋地域20％、中南米10％、中東アフリカ5%

主要企業
• Thermo Fisher Scientific, Inc. (US)
• Merck KGaA (Germany)
• Lonza Group (Switzerland)
• Danaher Corporation (US)
• Sartorius AG (Germany)
• Becton, Dickinson, and Company (US)
• Eppendorf AG (Germany)
• Corning Inc. (US)
• Bio-Rad Laboratories (US)
• Takara Bio Group (Japan)
• Fujifilm Holdings Corporation (Japan)
• Getinge AB (Sweden)
• Terumo Corporation (Japan)
• Bio-Techne Corporation (US)
• HiMedia Laboratories (India)
• StemCell Technologies, Inc. (Canada)
• Miltenyi Biotec GmBH (Germany)
• PromoCell (Germany), Anterogen Co. Ltd. (South Korea)
• CellGenix GmBH (India)
• Pluristem Therapeutics Inc. (Israel)
• Daiichi Sankyo (Japan)
• Organogenesis Holdings Inc. (US)
• Vericel Corporation (US)
• American Cryostem Corporation (US)

調査範囲
この調査レポートは、幹細胞製造市場の詳細な状況を掲載しています。製品（消耗品（培地、その他消耗品）、器具（バイオリアクター＆インキュベーター、セルソーター、その他器具）、幹細胞株（造血幹細胞、間葉系幹細胞、人工多能性幹細胞、胚性幹細胞、神経幹細胞、多能性成体前駆幹細胞）など、異なるセグメントにわたる市場規模や今後の成長可能性を推定することを目的としています、 用途（研究用途（生命科学研究、創薬・薬剤開発）、臨床用途（同種幹細胞治療、自家幹細胞治療）、細胞・組織バンク用途）、エンドユーザー（病院・手術センター、製薬・バイオテクノロジー企業、細胞・組織バンク、学術機関、研究所、CRO、その他エンドユーザー）、地域（北米、欧州、アジア太平洋、中南米、中東アフリカ）。また、主要市場プレイヤーの会社概要、最近の動向、主要市場戦略とともに、詳細な競合分析も掲載しています。

レポート購入の主な利点
本レポートは、幹細胞製造市場全体とそのセグメントにおける収益数の最も近い概算値を提供することで、市場リーダーや新規参入者を支援します。また、利害関係者が競合状況をよりよく理解し、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てるための洞察を深めるのにも役立ちます。本レポートは、関係者が市場の鼓動を理解し、主要な市場促進要因、阻害要因、動向、機会、課題に関する情報を提供することを可能にします。

本レポートは、以下のポイントに関する洞察を提供します：
- 主な促進要因（幹細胞研究に対するベンチャーキャピタルからの投資の増加、幹細胞製品の治療効果に関する意識の高まり、幹細胞製造における技術的進歩）、阻害要因（幹細胞の製造やバンキングに関連する多額の運営コスト）、機会（アジア太平洋地域における新しいワクチンの開発や遺伝性疾患の治療、 幹細胞製造市場の成長に影響を与える課題（製造スケールアップに伴う技術的限界、同種幹細胞やヒト胚性幹細胞の使用に関連する社会倫理的懸念）
- 製品開発/イノベーション：幹細胞製造市場における今後の技術、研究開発活動、新製品発表に関する詳細な洞察
- 市場開発： 有利な市場に関する包括的な情報、様々な地域における幹細胞製造市場を分析
- 市場の多様化：幹細胞製造市場における新製品、未開拓の地域、最近の開発、投資に関する詳細な情報
- 競合他社の評価：幹細胞製造市場戦略におけるMerck KGaA (Germany), Lonza Group (Switzerland), and Danaher Corporation (US)などの主要企業の市場シェア、成長戦略、サービス内容を詳細に評価。また、幹細胞製造市場の脈拍を理解し、主要な市場促進要因、阻害要因、課題、機会に関する情報を関係者に提供

1. イントロダクション
2. 調査方法
3. エグゼクティブサマリー
4. プレミアムインサイト
5. 市場概要
6. 幹細胞製造市場：製品別
7. 幹細胞製造市場：用途別
8. 幹細胞製造市場：エンドユーザー別
9. 幹細胞製造市場：地域別
10. 競争状況
11. 企業情報
12. 付録

❖ レポートの目次 ❖

1 INTRODUCTION 39
1.1 STUDY OBJECTIVES 39
1.2 MARKET DEFINITION 39
1.2.1 INCLUSIONS & EXCLUSIONS 40
1.3 MARKET SCOPE 40
1.3.1 MARKETS COVERED 40
1.4 YEARS CONSIDERED 41
1.5 CURRENCY 41
1.6 RESEARCH LIMITATIONS 41
1.7 STAKEHOLDERS 41
1.8 SUMMARY OF CHANGES 42
1.9 RECESSION IMPACT 42
2 RESEARCH METHODOLOGY 43
2.1 RESEARCH DATA 43
FIGURE 1 STEM CELL MANUFACTURING MARKET: RESEARCH DESIGN 43
2.1.1 SECONDARY DATA 44
2.1.2 PRIMARY DATA 45
FIGURE 2 STEM CELL MANUFACTURING MARKET: BREAKDOWN OF PRIMARIES 45
2.2 MARKET ESTIMATION METHODOLOGY 46
FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022 46
FIGURE 4 STEM CELL MANUFACTURING MARKET SIZE (2022) 47
FIGURE 5 STEM CELL MANUFACTURING MARKET: FINAL CAGR PROJECTIONS (2023−2028) 47
FIGURE 6 STEM CELL MANUFACTURING MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 48
2.3 MARKET DATA ESTIMATION AND TRIANGULATION 49
2.3.1 DATA TRIANGULATION 49
FIGURE 7 DATA TRIANGULATION METHODOLOGY 49
2.4 INDUSTRY INSIGHTS 50
2.5 RESEARCH ASSUMPTIONS 50
2.6 STEM CELL MANUFACTURING MARKET: GLOBAL RECESSION IMPACT 51
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 51
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 51
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 51
 
3 EXECUTIVE SUMMARY 53
FIGURE 8 STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2023 VS. 2028 (USD MILLION) 53
FIGURE 9 STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2023 VS. 2028 (USD MILLION) 54
FIGURE 10 STEM CELL MANUFACTURING MARKET: GEOGRAPHICAL SNAPSHOT 55
4 PREMIUM INSIGHTS 56
4.1 STEM CELL MANUFACTURING MARKET OVERVIEW 56
FIGURE 11 GROWING INVESTMENTS IN STEM CELL-BASED RESEARCH TO DRIVE MARKET GROWTH 56
4.2 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY PRODUCT AND COUNTRY (2023) 57
FIGURE 12 CONSUMABLES TO ACCOUNT FOR LARGEST MARKET SHARE IN 2023 57
4.3 STEM CELL MANUFACTURING MARKET, BY END USER (2023 VS. 2028) 57
FIGURE 13 PHARMACEUTICAL & BIOTECH COMPANIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 57
5 MARKET OVERVIEW 58
5.1 INTRODUCTION 58
5.2 MARKET DYNAMICS 58
FIGURE 14 STEM CELL MANUFACTURING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58
TABLE 4 STEM CELL MANUFACTURING MARKET: IMPACT ANALYSIS 59
5.2.1 DRIVERS 59
5.2.1.1 Growing venture capital investments in stem cell research 59
5.2.1.2 Increasing awareness about therapeutic potency of stem cell products 60
5.2.1.3 Technological advancements in stem cell manufacturing 61
5.2.2 RESTRAINTS 61
5.2.2.1 Significant operational costs associated with stem cell manufacturing and banking 61
5.2.3 OPPORTUNITIES 62
5.2.3.1 Supportive regulatory framework across developing economies 62
5.2.3.2 Government initiatives to boost biotechnology and biopharmaceutical industries 62
5.2.3.3 Increased market focus on mesenchymal stem cells and induced pluripotent stem cells 63
5.2.4 CHALLENGES 64
5.2.4.1 Technical limitations associated with manufacturing scale-up 64
5.2.4.2 Socio-ethical concerns related to use of allogeneic and human embryonic stem cells 64
5.3 TECHNOLOGY ANALYSIS 65
TABLE 5 SINGLE-USE BIOREACTORS VS. STAINLESS STEEL BIOREACTORS 65
 
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 66
FIGURE 15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 66
5.5 SUPPLY CHAIN ANALYSIS 67
FIGURE 16 STEM CELL MANUFACTURING MARKET: SUPPLY CHAIN ANALYSIS 68
5.6 VALUE CHAIN ANALYSIS 68
FIGURE 17 STEM CELL MANUFACTURING MARKET: VALUE CHAIN ANALYSIS 69
5.7 ECOSYSTEM ANALYSIS 69
FIGURE 18 STEM CELL MANUFACTURING MARKET: ECOSYSTEM ANALYSIS 69
5.8 PORTER’S FIVE FORCES ANALYSIS 70
TABLE 6 STEM CELL MANUFACTURING MARKET: PORTER’S FIVE FORCES ANALYSIS 70
5.8.1 INTENSITY OF COMPETITIVE RIVALRY 70
5.8.2 BARGAINING POWER OF SUPPLIERS 70
5.8.3 BARGAINING POWER OF BUYERS 70
5.8.4 THREAT OF SUBSTITUTES 70
5.8.5 THREAT OF NEW ENTRANTS 71
5.9 REGULATORY ANALYSIS 71
5.9.1 FDA APPROVALS 71
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 10 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 11 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
5.10 PRICING ANALYSIS 77
TABLE 12 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS 77
5.10.1 AVERAGE SELLING PRICE TREND ANALYSIS 77
5.11 PATENT ANALYSIS 78
FIGURE 19 GRANTED PATENTS FOR STEM CELL MANUFACTURING, 2011–2023* 78
TABLE 13 TOP OWNERS OF STEM CELL MANUFACTURING PATENTS 78
5.12 KEY CONFERENCES & EVENTS IN 2023–2024 79
TABLE 14 STEM CELL MANUFACTURING CONFERENCES (2023–2024) 79
5.13 KEY STAKEHOLDERS & BUYING CRITERIA 80
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 80
FIGURE 20 STEM CELL MANUFACTURING MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 80
5.13.2 STEM CELL MANUFACTURING MARKET: BUYING CRITERIA 80
FIGURE 21 KEY BUYING CRITERIA FOR END USERS 80
6 STEM CELL MANUFACTURING MARKET, BY PRODUCT 81
6.1 INTRODUCTION 82
TABLE 15 STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION) 82
6.2 CONSUMABLES 82
TABLE 16 STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE,
2021–2028 (USD MILLION) 83
TABLE 17 STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY REGION, 2021–2028 (USD MILLION) 83
TABLE 18 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 83
TABLE 19 EUROPE: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES,
BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 20 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 84
6.2.1 CULTURE MEDIA 84
6.2.1.1 Rising stem cell research and increasing demand for stem cell therapies to boost adoption of culture media 84
TABLE 21 STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA, BY REGION, 2021–2028 (USD MILLION) 85
TABLE 22 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 23 EUROPE: STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA,
BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 24 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA, BY COUNTRY, 2021–2028 (USD MILLION) 86
6.2.2 OTHER CONSUMABLES 86
TABLE 25 STEM CELL MANUFACTURING MARKET FOR OTHER CONSUMABLES,
BY REGION, 2021–2028 (USD MILLION) 87
TABLE 26 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 27 EUROPE: STEM CELL MANUFACTURING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 28 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 88
6.3 INSTRUMENTS 88
TABLE 29 STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 89
TABLE 30 STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION) 89
TABLE 31 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 32 EUROPE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 33 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY COUNTRY, 2021–2028 (USD MILLION) 90
6.3.1 BIOREACTORS & INCUBATORS 91
6.3.1.1 Introduction of advanced bioreactors and incubators to contribute to market growth 91
TABLE 34 STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS, BY REGION, 2021–2028 (USD MILLION) 91
TABLE 35 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 36 EUROPE: STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 37 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS, BY COUNTRY, 2021–2028 (USD MILLION) 93
6.3.2 CELL SORTERS 93
6.3.2.1 Development of novel cell sorting technologies such as microfluidics to drive market 93
TABLE 38 STEM CELL MANUFACTURING MARKET FOR CELL SORTERS, BY REGION, 2021–2028 (USD MILLION) 94
TABLE 39 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 40 EUROPE: STEM CELL MANUFACTURING MARKET FOR CELL SORTERS,
BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 41 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CELL SORTERS,
BY COUNTRY, 2021–2028 (USD MILLION) 95
6.3.3 OTHER INSTRUMENTS 96
TABLE 42 STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS,
BY REGION, 2021–2028 (USD MILLION) 96
TABLE 43 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 44 EUROPE: STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 45 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 97
6.4 STEM CELL LINES 97
TABLE 46 STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 98
TABLE 47 STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY REGION, 2021–2028 (USD MILLION) 98
TABLE 48 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 49 EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 50 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION) 100
6.4.1 HEMATOPOIETIC STEM CELLS 100
6.4.1.1 Increasing adoption of cord blood banking to boost market 100
TABLE 51 STEM CELL MANUFACTURING MARKET FOR HEMATOPOIETIC STEM CELLS,
BY REGION, 2021–2028 (USD MILLION) 101
TABLE 52 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 53 EUROPE: STEM CELL MANUFACTURING MARKET FOR HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 54 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 102
6.4.2 MESENCHYMAL STEM CELLS 102
6.4.2.1 Ease of cell harvesting, processing, and preservation to drive adoption of MSCs 102
TABLE 55 STEM CELL MANUFACTURING MARKET FOR MESENCHYMAL STEM CELLS,
BY REGION, 2021–2028 (USD MILLION) 103
TABLE 56 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR MESENCHYMAL STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 57 EUROPE: STEM CELL MANUFACTURING MARKET FOR MESENCHYMAL STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 58 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR MESENCHYMAL STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 104
6.4.3 INDUCED PLURIPOTENT STEM CELLS 105
6.4.3.1 Increased adoption of iPSCs in research on cell therapies & regenerative medicine to fuel growth 105
TABLE 59 STEM CELL MANUFACTURING MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2021–2028 (USD MILLION) 105
TABLE 60 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 61 EUROPE: STEM CELL MANUFACTURING MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 62 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 107
6.4.4 EMBRYONIC STEM CELLS 107
6.4.4.1 Rising research activity in cancer precision medicine to contribute to segmental growth 107
TABLE 63 STEM CELL MANUFACTURING MARKET FOR EMBRYONIC STEM CELLS,
BY REGION, 2021–2028 (USD MILLION) 108
TABLE 64 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 65 EUROPE: STEM CELL MANUFACTURING MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 66 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 109
6.4.5 NEURAL STEM CELLS 110
6.4.5.1 Introduction of novel isolation and expansion techniques for NSCs to drive market 110
TABLE 67 STEM CELL MANUFACTURING MARKET FOR NEURAL STEM CELLS,
BY REGION, 2021–2028 (USD MILLION) 110
TABLE 68 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR NEURAL STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 69 EUROPE: STEM CELL MANUFACTURING MARKET FOR NEURAL STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 70 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR NEURAL STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 111
6.4.6 MULTIPOTENT ADULT PROGENITOR STEM CELLS 111
6.4.6.1 Rising awareness of role of MAPCs in research to propel market 111
TABLE 71 STEM CELL MANUFACTURING MARKET FOR MULTIPOTENT ADULT PROGENITOR STEM CELLS, BY REGION, 2021–2028 (USD MILLION) 112
TABLE 72 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR MULTIPOTENT ADULT PROGENITOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 73 EUROPE: STEM CELL MANUFACTURING MARKET FOR MULTIPOTENT ADULT PROGENITOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 74 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR MULTIPOTENT ADULT PROGENITOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 113
7 STEM CELL MANUFACTURING MARKET, BY APPLICATION 114
7.1 INTRODUCTION 115
TABLE 75 STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION) 115
7.2 RESEARCH APPLICATIONS 116
TABLE 76 STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2021–2028 (USD MILLION) 116
TABLE 77 STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS,
BY REGION, 2021–2028 (USD MILLION) 117
TABLE 78 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 79 EUROPE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 80 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 118
7.2.1 LIFE SCIENCE RESEARCH 118
7.2.1.1 Increasing research focus on stem cell cytology & pathology to boost market 118
TABLE 81 STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH,
BY REGION, 2021–2028 (USD MILLION) 119
TABLE 82 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 83 EUROPE: STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 84 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 120
7.2.2 DRUG DISCOVERY & DEVELOPMENT 120
7.2.2.1 Increasing research expenditure by pharma and biotech companies to contribute to market growth 120
TABLE 85 STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION) 121
TABLE 86 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 87 EUROPE: STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 88 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 123
 
7.3 CLINICAL APPLICATIONS 123
TABLE 89 STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS,
BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 90 STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS,
BY REGION, 2021–2028 (USD MILLION) 124
TABLE 91 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 92 EUROPE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 93 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 125
7.3.1 ALLOGENEIC STEM CELL THERAPY 125
7.3.1.1 Wide therapeutic applications of stem cell lines to drive growth 125
TABLE 94 STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY REGION, 2021–2028 (USD MILLION) 126
TABLE 95 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 96 EUROPE: STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 97 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 127
7.3.2 AUTOLOGOUS STEM CELL THERAPY 127
7.3.2.1 Increasing patient preference for autologous stem cell therapy to drive segmental growth 127
TABLE 98 STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY REGION, 2021–2028 (USD MILLION) 128
TABLE 99 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 100 EUROPE: STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 101 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 129
7.4 CELL & TISSUE BANKING APPLICATIONS 129
7.4.1 RISING DEMAND FOR CORD BLOOD STEM CELL BANKING TO FAVOR MARKET GROWTH 129
TABLE 102 STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 130
TABLE 103 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 104 EUROPE: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 105 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 131
 
8 STEM CELL MANUFACTURING MARKET, BY END USER 132
8.1 INTRODUCTION 133
TABLE 106 STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION) 133
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 134
8.2.1 INCREASING PRIVATE INVESTMENTS FOR STEM CELL-BASED RESEARCH TO DRIVE MARKET GROWTH 134
TABLE 107 STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 134
TABLE 108 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2021–2028 (USD MILLION) 135
TABLE 109 EUROPE: STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 110 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 136
8.3 ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CONTRACT RESEARCH ORGANIZATIONS 136
8.3.1 INCREASED PUBLIC FUNDING FOR RESEARCH ACTIVITIES TO BOOST MARKET 136
TABLE 111 STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CROS, BY REGION,
2021–2028 (USD MILLION) 137
TABLE 112 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CROS, BY COUNTRY,
2021–2028 (USD MILLION) 137
TABLE 113 EUROPE: STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CROS, BY COUNTRY,
2021–2028 (USD MILLION) 138
TABLE 114 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CROS, BY COUNTRY,
2021–2028 (USD MILLION) 138
8.4 HOSPITALS & SURGICAL CENTERS 138
8.4.1 IMPROVED HEALTHCARE INFRASTRUCTURE TO PROPEL GROWTH 138
TABLE 115 STEM CELL MANUFACTURING MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2021–2028 (USD MILLION) 139
TABLE 116 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR HOSPITALS & SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 117 EUROPE: STEM CELL MANUFACTURING MARKET FOR HOSPITALS & SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 118 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR HOSPITALS & SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 140
8.5 CELL & TISSUE BANKS 140
8.5.1 GROWING APPLICATION OF STEM CELLS IN DISEASE TREATMENT TO FAVOR MARKET GROWTH 140
TABLE 119 STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKS, BY REGION, 2021–2028 (USD MILLION) 141
TABLE 120 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKS, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 121 EUROPE: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKS, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 122 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKS, BY COUNTRY, 2021–2028 (USD MILLION) 142
8.6 OTHER END USERS 143
TABLE 123 STEM CELL MANUFACTURING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 143
TABLE 124 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 125 EUROPE: STEM CELL MANUFACTURING MARKET FOR OTHER END USERS,
BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 126 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 144
9 STEM CELL MANUFACTURING MARKET, BY REGION 145
9.1 INTRODUCTION 146
TABLE 127 STEM CELL MANUFACTURING MARKET, BY REGION,
2021–2028 (USD MILLION) 146
9.2 NORTH AMERICA 146
FIGURE 22 NORTH AMERICA: STEM CELL MANUFACTURING MARKET SNAPSHOT 147
TABLE 128 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 129 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 148
TABLE 130 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 148
TABLE 131 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 148
TABLE 132 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 133 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 149
TABLE 134 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 150
TABLE 135 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 150
TABLE 136 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY END USER, 2021–2028 (USD MILLION) 151
9.2.1 US 151
9.2.1.1 Continued focus to strengthen R&D to drive market in US 151
TABLE 137 US: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION) 152
TABLE 138 US: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 139 US: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 140 US: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 141 US: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION) 154
TABLE 142 US: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 143 US: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS,
BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 144 US: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION) 156
9.2.2 CANADA 156
9.2.2.1 Rising government investments to drive market in Canada 156
TABLE 145 CANADA: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION) 157
TABLE 146 CANADA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES,
BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 147 CANADA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 148 CANADA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 149 CANADA: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION) 158
TABLE 150 CANADA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 151 CANADA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 152 CANADA: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION) 160
9.2.3 NORTH AMERICA: IMPACT OF RECESSION 160
9.3 EUROPE 161
TABLE 153 EUROPE: STEM CELL MANUFACTURING MARKET, BY COUNTRY,
2021–2028 (USD MILLION) 161
TABLE 154 EUROPE: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION) 162
TABLE 155 EUROPE: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES,
BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 156 EUROPE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 157 EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 158 EUROPE: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION) 163
TABLE 159 EUROPE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 160 EUROPE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 161 EUROPE: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION) 165
 
9.3.1 GERMANY 165
9.3.1.1 Strong growth in biotechnology industry to drive market 165
TABLE 162 GERMANY: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION) 166
TABLE 163 GERMANY: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES,
BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 164 GERMANY: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 165 GERMANY: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 166 GERMANY: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION) 167
TABLE 167 GERMANY: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 168 GERMANY: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 169 GERMANY: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION) 169
9.3.2 FRANCE 169
9.3.2.1 Government support in stem cell manufacturing to drive market 169
TABLE 170 FRANCE: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION) 170
TABLE 171 FRANCE: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES,
BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 172 FRANCE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 173 FRANCE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 174 FRANCE: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION) 171
TABLE 175 FRANCE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 176 FRANCE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 177 FRANCE: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION) 173
9.3.3 UK 173
9.3.3.1 Growing focus on innovation to increase demand for stem cell-based therapeutics 173
TABLE 178 UK: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION) 174
TABLE 179 UK: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 180 UK: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 181 UK: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 182 UK: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION) 175
TABLE 183 UK: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 184 UK: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS,
BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 185 UK: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION) 177
9.3.4 ITALY 177
9.3.4.1 Initiatives encouraging development of cell & gene therapy to boost demand for stem cell manufacturing 177
TABLE 186 ITALY: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION) 178
TABLE 187 ITALY: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 188 ITALY: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 189 ITALY: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 190 ITALY: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION) 179
TABLE 191 ITALY: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 192 ITALY: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 193 ITALY: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION) 181
9.3.5 SPAIN 181
9.3.5.1 Increasing demand for precision medicine to drive growth 181
TABLE 194 SPAIN: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION) 182
TABLE 195 SPAIN: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 196 SPAIN: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 197 SPAIN: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 198 SPAIN: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION) 183
TABLE 199 SPAIN: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 200 SPAIN: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 201 SPAIN: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION) 185
9.3.6 REST OF EUROPE 185
TABLE 202 REST OF EUROPE: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 186
TABLE 203 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 204 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 205 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 206 REST OF EUROPE: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 188
TABLE 207 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 208 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 209 REST OF EUROPE: STEM CELL MANUFACTURING MARKET, BY END USER, 2021–2028 (USD MILLION) 189
9.3.7 EUROPE: IMPACT OF RECESSION 189
9.4 ASIA PACIFIC 189
FIGURE 23 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET SNAPSHOT 190
TABLE 210 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET, BY COUNTRY,
2021–2028 (USD MILLION) 191
TABLE 211 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION) 191
TABLE 212 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 213 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 214 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 215 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 193
TABLE 216 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 217 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 218 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION) 194

9.4.1 CHINA 194
9.4.1.1 Increasing clinical trials for stem cells and innovations to drive market 194
TABLE 219 CHINA: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION) 195
TABLE 220 CHINA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 221 CHINA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 222 CHINA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 223 CHINA: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION) 196
TABLE 224 CHINA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 225 CHINA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 226 CHINA: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION) 198
9.4.2 JAPAN 198
9.4.2.1 Growing collaborations for stem cell research to drive growth 198
TABLE 227 JAPAN: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION) 199
TABLE 228 JAPAN: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 229 JAPAN: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 230 JAPAN: STEM CELL MANUFACTURING MARKET FOR S
9.4 ASIA PACIFIC 189
FIGURE 23 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET SNAPSHOT 190
TABLE 210 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET, BY COUNTRY,
2021–2028 (USD MILLION) 191
TABLE 211 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION) 191
TABLE 212 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 213 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 214 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 215 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 193
TABLE 216 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 217 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 218 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION) 194
9.4.1 CHINA 194
9.4.1.1 Increasing clinical trials for stem cells and innovations to drive market 194
TABLE 219 CHINA: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION) 195
TABLE 220 CHINA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 221 CHINA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 222 CHINA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 223 CHINA: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION) 196
TABLE 224 CHINA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 225 CHINA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 226 CHINA: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION) 198
9.4.2 JAPAN 198
9.4.2.1 Growing collaborations for stem cell research to drive growth 198
TABLE 227 JAPAN: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION) 199
TABLE 228 JAPAN: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 229 JAPAN: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 230 JAPAN: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 231 JAPAN: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION) 200
TABLE 232 JAPAN: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 233 JAPAN: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 234 JAPAN: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION) 202
9.4.3 INDIA 202
9.4.3.1 Increasing prevalence of genetic disorders to support growth 202
TABLE 235 INDIA: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION) 203
TABLE 236 INDIA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 237 INDIA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 238 INDIA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 239 INDIA: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION) 204
TABLE 240 INDIA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 241 INDIA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 242 INDIA: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION) 206
9.4.4 REST OF ASIA PACIFIC 206
TABLE 243 REST OF ASIA PACIFIC: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 207
TABLE 244 REST OF ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 245 REST OF ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 246 REST OF ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 247 REST OF ASIA PACIFIC: STEM CELL MANUFACTURING MARKET,
BY APPLICATION, 2021–2028 (USD MILLION) 208
TABLE 248 REST OF ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 209
TABLE 249 REST OF ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 209
TABLE 250 REST OF ASIA PACIFIC: STEM CELL MANUFACTURING MARKET, BY END USER, 2021–2028 (USD MILLION) 210
9.4.5 ASIA PACIFIC: IMPACT OF RECESSION 210
9.5 LATIN AMERICA 211
9.5.1 GROWING PHARMACEUTICAL INDUSTRY IN REGION TO DRIVE MARKET GROWTH 211
TABLE 251 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 211
TABLE 252 LATIN AMERICA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 253 LATIN AMERICA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 254 LATIN AMERICA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 255 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 213
TABLE 256 LATIN AMERICA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 257 LATIN AMERICA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 258 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, BY END USER, 2021–2028 (USD MILLION) 214
9.5.2 LATIN AMERICA: IMPACT OF RECESSION 214
9.6 MIDDLE EAST & AFRICA 214
9.6.1 INCREASING FUNDING AND COLLABORATIONS TO DRIVE MARKET GROWTH 214
TABLE 259 MIDDLE EAST & AFRICA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 215
TABLE 260 MIDDLE EAST & AFRICA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 261 MIDDLE EAST & AFRICA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 262 MIDDLE EAST & AFRICA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 216
TABLE 263 MIDDLE EAST & AFRICA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 216
TABLE 264 MIDDLE EAST & AFRICA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 265 MIDDLE EAST & AFRICA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 266 MIDDLE EAST & AFRICA: STEM CELL MANUFACTURING MARKET, BY END USER, 2021–2028 (USD MILLION) 218
9.6.2 MIDDLE EAST & AFRICA: IMPACT OF RECESSION 218
10 COMPETITIVE LANDSCAPE 219
10.1 INTRODUCTION 219
10.2 KEY STRATEGIES ADOPTED BY PLAYERS 219
FIGURE 24 STEM CELL MANUFACTURING MARKET: STRATEGIES ADOPTED BY KEY PLAYERS 220
10.3 REVENUE SHARE ANALYSIS OF TOP 5 PLAYERS 221
FIGURE 25 REVENUE SHARE ANALYSIS FOR TOP 5 COMPANIES (2020−2022) 221
10.4 MARKET SHARE ANALYSIS OF TOP 5 PLAYERS 222
FIGURE 26 STEM CELL MANUFACTURING MARKET: MARKET SHARE ANALYSIS OF TOP 5 PLAYERS (2022) 222
10.5 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS 224
FIGURE 27 STEM CELL MANUFACTURING MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 225
10.5.1 STARS 225
10.5.2 EMERGING LEADERS 225
10.5.3 PERVASIVE PLAYERS 226
10.5.4 PARTICIPANTS 226
10.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES 226
10.6.1 PROGRESSIVE COMPANIES 226
10.6.2 STARTING BLOCKS 226
10.6.3 RESPONSIVE COMPANIES 226
10.6.4 DYNAMIC COMPANIES 227
FIGURE 28 STEM CELL MANUFACTURING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 227
10.7 COMPETITIVE BENCHMARKING 228
10.7.1 STEM CELL MANUFACTURING MARKET: DETAILED LIST OF START-UPS/SMES 228
TABLE 267 STEM CELL MANUFACTURING MARKET: DETAILED LIST OF START-UPS/SMES 228
10.8 STEM CELL MANUFACTURING MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES 229
TABLE 268 STEM CELL MANUFACTURING MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES 229
10.9 COMPETITIVE SCENARIO AND TRENDS 230
TABLE 269 STEM CELL MANUFACTURING MARKET: PRODUCT LAUNCHES (2021–2023) 230
TABLE 270 STEM CELL MANUFACTURING MARKET: DEALS (2021–2023) 230
TABLE 271 STEM CELL MANUFACTURING MARKET: OTHER DEVELOPMENTS (2021–2023) 232
 
11 COMPANY PROFILES 233
11.1 KEY PLAYERS 233
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
11.1.1 THERMO FISHER SCIENTIFIC, INC. 233
TABLE 272 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW 233
FIGURE 29 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022) 234
11.1.2 MERCK KGAA 240
TABLE 273 MERCK KGAA: COMPANY OVERVIEW 240
FIGURE 30 MERCK KGAA: COMPANY SNAPSHOT (2022) 241
11.1.3 LONZA GROUP 246
TABLE 274 LONZA GROUP: COMPANY OVERVIEW 246
FIGURE 31 LONZA GROUP: COMPANY SNAPSHOT (2022) 247
11.1.4 DANAHER CORPORATION 254
TABLE 275 DANAHER CORPORATION: COMPANY OVERVIEW 254
FIGURE 32 DANAHER CORPORATION: COMPANY SNAPSHOT (2022) 255
11.1.5 SARTORIUS AG 259
TABLE 276 SARTORIUS AG: COMPANY OVERVIEW 259
FIGURE 33 SARTORIUS AG: COMPANY SNAPSHOT (2022) 260
11.1.6 BECTON, DICKINSON AND COMPANY 264
TABLE 277 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 264
FIGURE 34 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 265
11.1.7 EPPENDORF SE 267
TABLE 278 EPPENDORF SE: COMPANY OVERVIEW 267
FIGURE 35 EPPENDORF SE: COMPANY SNAPSHOT (2022) 268
11.1.8 CORNING INCORPORATED 270
TABLE 279 CORNING INCORPORATED: COMPANY OVERVIEW 270
FIGURE 36 CORNING INCORPORATED: COMPANY SNAPSHOT (2022) 271
11.1.9 BIO-RAD LABORATORIES, INC. 273
TABLE 280 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 273
FIGURE 37 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022) 274
11.1.10 TAKARA BIO INC. 278
TABLE 281 TAKARA BIO INC.: COMPANY OVERVIEW 278
FIGURE 38 TAKARA BIO INC.: COMPANY SNAPSHOT (2022) 279
11.1.11 FUJIFILM HOLDINGS CORPORATION 282
TABLE 282 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW 282
FIGURE 39 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022) 283
11.1.12 GETINGE AB 288
TABLE 283 GETINGE AB: COMPANY OVERVIEW 288
FIGURE 40 GETINGE AB: COMPANY SNAPSHOT (2022) 289
11.1.13 TERUMO CORPORATION 291
TABLE 284 TERUMO CORPORATION: COMPANY OVERVIEW 291
FIGURE 41 TERUMO CORPORATION: COMPANY SNAPSHOT (2022) 292
11.1.14 BIO-TECHNE CORPORATION 294
TABLE 285 BIO-TECHNE CORPORATION: COMPANY OVERVIEW 294
FIGURE 42 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2022) 295
11.1.15 HIMEDIA LABORATORIES PVT. LTD. 299
TABLE 286 HIMEDIA LABORATORIES PVT. LTD.: COMPANY OVERVIEW 299
11.2 OTHER PLAYERS 301
11.2.1 STEMCELL TECHNOLOGIES, INC. 301
11.2.2 MILTENYI BIOTEC GMBH 301
11.2.3 PROMOCELL 302
11.2.4 ANTEROGEN CO. LTD. 302
11.2.5 CELLGENIX GMBH 303
11.2.6 PLURISTEM THERAPEUTICS INC. 303
11.2.7 DAIICHI SANKYO 304
11.2.8 ORGANOGENESIS HOLDINGS INC. 304
11.2.9 VERICEL CORP. 305
11.2.10 AMERICAN CRYOSTEM CORP. 305
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12 APPENDIX 306
12.1 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 309
12.2 CUSTOMIZATION OPTIONS 311
12.3 RELATED REPORTS 311
12.4 AUTHOR DETAILS 312

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 幹細胞製造の世界市場予測（～2028）：製品別、用途別、エンドユーザー別、地域別(Stem Cell Manufacturing Market by Product (Consumables, Instruments, Stem Cell Lines), Application (Research, Clinical, Cell Tissue & Banking), End User, Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
グローバルリサーチ調査資料のイメージグローバルリサーチ調査資料のイメージ
◆関連リサーチレポート◆
  • 細胞培養培地の世界市場予測（～2028）：種類別、用途別、エンドユーザー別、地域別
  • シングルユースバイオリアクター（SUB）の世界市場予測（～2028）：製品別、種類別、細胞タイプ別、分子別、エンドユーザー別、地域別
  • 細胞単離/細胞分離の世界市場予測（～2028年）：製品別、細胞別、細胞源別、技術別、用途別、エンドユーザー別
  • ヒト胚性幹細胞（ES細胞）の世界市場予測（〜2030年）
  • フローサイトメトリーの世界市場予測（～2028）：技術別、製品＆サービス別、用途別、エンドユーザー別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆